A total of 16 patients with trastuzumab-resistant breast cancer were tested using NGS in our hospital, in these patients, the frequency of genetic changes was ranked as the top four in the order of TP53, PIK3CA, CDK12 and CYP2C19 (Fig. 4C). This evidence concerns the gene CDK12 and breast cancer.